Clin2
NCT07764211Possibly a fitNot yet recruiting

A study of generalized anxiety disorder to learn more about it

Generalized Anxiety Disorder (GAD)

Part of Mental health clinical trials.

This study aims to better understand generalized anxiety disorder by following a group of people over time. You won't receive a new treatment, but you will help researchers learn more about the condition, which may lead to better care in the future.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
400 people
Ages
18 years to 65 years
Study type
Observational

Who can take part

  • You are between 18 and 65 years old.
  • You have been diagnosed with generalized anxiety disorder (GAD) by a doctor.
  • Your anxiety symptoms are significant, as measured by a standard scale (HAMA score >14).
  • You have at least a junior high school education and can complete questionnaires.
  • You do not have any other major mental health conditions, serious suicidal thoughts, or uncontrolled medical problems.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07123467Recruiting· Phase 3
Study on CBD and learning for generalized anxiety

This trial tests if adding cannabidiol (CBD) to a learning-based approach helps manage generalized anxiety disorder (GAD). It involves brain scans and taking CBD daily.

Detroit, Michigan
NCT06846320Recruiting· Phase 2
Study of ABBV-932 for generalized anxiety disorder

This trial tests an oral medicine called ABBV-932 when added to current antidepressant therapy for people with generalized anxiety disorder (GAD) who still have symptoms. It aims to see if the combination can improve anxiety and reduce side effects.

Huntsville, Alabama
NCT06969170Recruiting· Phase 2
Psilocybin oral solution for generalized anxiety disorder trial

This study tests a psilocybin oral solution in adults with generalized anxiety disorder (GAD). It aims to see if the drug is safe, tolerable, and helpful for reducing anxiety symptoms.

Kingston, Ontario
NCT06775145Not yet recruiting
Using brain stimulation to treat anxiety disorders

This trial tests a non-invasive brain stimulation technique called high-definition transcranial electrical stimulation (HD-tES) to see if it can help people with Generalized Anxiety Disorder (GAD). If you have GAD and have been stable on your current treatment, this study may be a good fit for you.

NCT07430800Recruiting
AI-Powered CBT for Anxiety in University Students

This study tests whether personalized computer models can improve cognitive behavioral therapy (a talk therapy that helps change thinking patterns) for anxiety. It's for university students who have mild to moderate anxiety and are comfortable with being recorded during sessions.

Los Angeles, California
NCT06254157Not yet recruiting
Understanding Participation in Anxiety Clinical Trials

This study looks at how people with generalized anxiety disorder (GAD) decide to join or stay in clinical trials. It is an observational study, meaning no new treatment is given—just tracking your participation experiences.

San Francisco, California

Hear when a new Generalized Anxiety Disorder (GAD) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.